Clinical Trial Update: Drug Rediscovery for Rare Immune Mediated Inflammatory Diseases [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for rediscovering a drug for rare immune-mediated inflammatory diseases, with recruitment ongoing for Behçet's disease, idiopath…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Behçet Disease
• Idiopathic Inflammatory Myopathies
• Igg4-related Disease

Snippet

Sponsor: UMC Utrecht | Conditions: Behcet's Disease, Idiopathic Inflammatory Myopathies | Phase 2 | Status: RECRUITING